Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies

被引:19
|
作者
Gottsäter, A [1 ]
Forsblad, J
Mätzsch, T
Persson, K
Ljungcrantz, I
Ohlsson, K
Lindgärde, F
机构
[1] Lund Univ, Malmo Univ Hosp, Dept Vasc Dis, S-20502 Malmo, Sweden
[2] Lund Univ, Malmo Univ Hosp, Dept Clin Microbiol, Malmo, Sweden
[3] Lund Univ, Malmo Univ Hosp, Dept Surg Pathophysiol, Malmo, Sweden
关键词
carotid artery stenosis; Chlamydia pneumoniae; interleukin-1 receptor antagonist; interleukin-1; beta; triglycerides;
D O I
10.1046/j.1365-2796.2002.00926.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To investigate whether the interleukin-1 receptor antagonist (Il-1ra) and interleukin-1beta (Il-1beta) can be detected in human carotid artery tissue, and whether their presence is related to evidence of Chlamydia pneumoniae infection, risk factors for atherosclerosis, and clinical data. Setting. Departments of Vascular Diseases and Surgical Pathophysiology, University Hospital, Malmo, Sweden. Subjects. A total of 66 patients undergoing carotid endarterectomy (median age 74, range 53-89 years, 20 women). Il-1beta and Il-1ra were studied in carotid artery plaques and in Il-1ra in serum. Results. Interleukin-1 receptor antagonist was detected in mononuclear cells in plaques from 37/ 66 (56%) patients. Patients with Il-1ra in plaques showed higher [2.04 (1.70-3.14) mmol L-1 vs. 1.69 (1.09-1.99) mmol L-1; P < 0.05] serum(s-)triglyceride(tg) levels, and a higher frequency of IgA seropositivity for C. pneumoniae (76% vs. 52%: P < 0.05) than those without. S-Il-1ra levels correlated with s-tg levels (r = 0.38; P = 0.047). There were no differences between patients with and without Il-1ra in plaques concerning s-Il-1ra, blood(b-)haemoglobin or leucocyte count, s-cholesterol, b-glucose, blood pressure, IgG seropositivity for C. pneumoniae, prevalence of neurological symptoms preceding operation, smoking, or diabetes mellitus. There were no differences in frequency of Il-1ra in plaques or in s-Il-1ra levels between patients with symptomatic and asymptomatic stenosis, between smokers and nonsmokers, or between diabetic and nondiabetic patients. Il-1beta was not detected in plaques in the current study. Conclusion. Interleukin-1 receptor antagonist can be detected in human atherosclerotic carotid artery plaques, and is related to s-triglyceride levels and IgA seropositivity for C. pneumoniae, but not to prevalence of neurological symptoms related to embolization.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 50 条
  • [31] Interleukin-1 receptor antagonist production in human and murine lens
    Kennedy, MC
    Planck, SR
    Ansel, JC
    Rosenbaum, JT
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 4539 - 4539
  • [32] Production of interleukin-1 receptor antagonist by human articular chondrocytes
    Gaby Palmer
    Pierre-Andre Guerne
    Francoise Mezin
    Michel Maret
    Jerome Guicheux
    Mary B Goldring
    Cem Gabay
    Arthritis Research & Therapy, 4
  • [33] CELLULAR SIGNALS FOR THE INDUCTION OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST
    CHANG, DM
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 74 (01): : 23 - 30
  • [34] INTERLEUKIN-1 RECEPTOR ANTAGONIST IN HUMAN EPIDERMIS AND CULTURED KERATINOCYTES
    GRUAZCHATELLARD, D
    BAUMBERGER, C
    SAURAT, JH
    DAYER, JM
    FEBS LETTERS, 1991, 294 (1-2): : 137 - 140
  • [35] Production of interleukin-1 receptor antagonist by human articular chondrocytes
    Palmer, G
    Guerne, PA
    Mezin, F
    Maret, M
    Guicheux, J
    Goldring, MB
    Gabay, C
    ARTHRITIS RESEARCH, 2002, 4 (03) : 226 - U20
  • [36] Elevated interleukin-1 receptor antagonist levels in pediatric sepsis syndrome
    Samson, LM
    Allen, UD
    Creery, WD
    DiazMitoma, F
    Singh, RN
    JOURNAL OF PEDIATRICS, 1997, 131 (04): : 587 - 591
  • [37] Umbilical cord levels of interleukin-1 receptor antagonist and neonatal outcome
    Elsmen, Emma
    Ley, David
    Cilio, Corrado M.
    Hansen-Pupp, Ingrid
    Hellstrom-Westas, Lena
    BIOLOGY OF THE NEONATE, 2006, 89 (04): : 220 - 226
  • [38] Increased serum levels of interleukin-1 receptor antagonist in human obesity: A link to the resistance to leptin?
    Meier, CA
    Bobbioni, E
    Gabay, C
    Assimacoloulos-Jeannet, F
    Golay, A
    Dayer, JM
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, : 94 - 94
  • [39] Interleukin-1β enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell cultures
    Sauer, J
    Renner, U
    Hopfner, U
    Lange, M
    Müller, A
    Strasburger, CJ
    Pagotto, U
    Arzt, E
    Stalla, GK
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07): : 2429 - 2434
  • [40] Human endometrial stromal interleukin-1 beta: Autocrine secretion and inhibition by interleukin-1 receptor antagonist
    Tanaka, T
    Sakamoto, T
    Mizuno, K
    Umesaki, N
    Ogita, S
    HORMONE RESEARCH, 2000, 53 (06) : 300 - 304